abt-614
Small moleculeexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Dec 1, 2008 (NCT00788801)
Timeline
2000s
- Jan 1, 2008
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Dopamine D4 receptorACTIVATOR
DRD4 activator
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- abt-614
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01464320 | Phase 1 | Nov 1, 2011 | Abbott |
| NCT00959816 | Phase 1 | Aug 1, 2009 | Abbott |
| NCT00788801 | Phase 1 | Dec 1, 2008 | Abbott |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Abbott | For profit | 3 | 3 | 1 | 2008 |
1 organizations
Page 1 / 1